Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV

Corporate Breaking News

Home : Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV

Jul 27 2020	Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV
LEUVEN, Belgium, July 27, 2020 /PRNewswire/ -- Fund+, an investment firm focused on innovative European Life Sciences companies, today announces that it has led the €38 million Series B financing in new portfolio company, Indigo Diabetes (Indigo). Indigo is developing a novel 'invisible'...


Source:https://prnmedia.prnewswire.com:443/news-releases/fund-leads-eur38-million-series-b-financing-in-indigo-diabetes-nv-301099522.html

Related News
» From The Alzheimer's Association International Conference 2020: Flu, Pneumonia Vaccinations Tied To Lower Risk Of Alzheimer's Dementia » Sohu.com to Report Second Quarter 2020 Financial Results on August 10, 2020